StageZero Life Sciences Ltd (SZLSh)

Currency in CAD
0.040
0.000(0.00%)
Closed·
SZLSh Scorecard
Full Analysis
Stock generally trades with low price volatility
Earnings results expected today
Trading near 52-week High
Trading near 52-week Low
SZLSh is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0400.040
52 wk Range
0.0400.040
Key Statistics
Bid/Ask
0.005 / 0.85
Prev. Close
0.04
Open
0.04
Day's Range
0.04-0.04
52 wk Range
0.04-0.04
Volume
-
Average Volume (3m)
295.06K
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SZLSh Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

StageZero Life Sciences Ltd Company Profile

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company’s lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual’s current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman’s risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.

Compare SZLSh to Peers and Sector

Metrics to compare
SZLSh
Peers
Sector
Relationship
P/E Ratio
-−4.9x−0.6x
PEG Ratio
-−0.020.00
Price/Book
-−0.8x2.6x
Price / LTM Sales
-2.7x3.3x
Upside (Analyst Target)
-75.3%39.1%
Fair Value Upside
Unlock−1.6%5.4%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

SZLSh Income Statement

FAQ

What Stock Exchange Does StageZero Life Sciences Trade On?

StageZero Life Sciences is listed and trades on the TSX Venture Exchange stock exchange.

What Is the Stock Symbol for StageZero Life Sciences?

The stock symbol for StageZero Life Sciences is "SZLSh."

What Is the StageZero Life Sciences Market Cap?

As of today, StageZero Life Sciences market cap is 4.94M.

What Is StageZero Life Sciences's Earnings Per Share (TTM)?

The StageZero Life Sciences EPS (TTM) is -0.12.

When Is the Next StageZero Life Sciences Earnings Date?

StageZero Life Sciences will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is SZLSh a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has StageZero Life Sciences Stock Split?

StageZero Life Sciences has split 2 times.

How Many Employees Does StageZero Life Sciences Have?

StageZero Life Sciences has 40 employees.

What is the current trading status of StageZero Life Sciences (SZLSh)?

As of 29 Aug 2025, StageZero Life Sciences (SZLSh) is trading at a price of 0.040, with a previous close of 0.04. The stock has fluctuated within a day range of 0.040 to 0.040, while its 52-week range spans from 0.040 to 0.040.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.